Literature DB >> 30786349

[Correlation between polymorphism of CYP19A1, GSTM1, GSTT1 and GSTP1 gene and endometriosis].

Y Tuo1, J Yang2, X J Chen1, F Liu1.   

Abstract

Objective: To study the association between polymorphisms in CYP19A1 rs2899470, GSTM1, GSTT1, and GSTP1 rs1695 and the development of endometriosis.
Methods: Between October 2015 and October 2017, 262 endometriosis patients and 275 control subjects were recruited from the Affiliated Hospital of Inner Mongolia Medical University. Genotyping was conducted using polymerase chain reaction-coupled with restriction fragment length polymorphism and multiplex allele specific polymerase chain reaction.
Results: Individuals carrying the TT genotype of CYP19A1 rs2899470 expressed a higher risk of endometriosis than that carrying the GG genotype (P<0.01), and the adjusted OR was 2.33 (95%CI 1.27-4.33). In addition, individuals with the CYP19A1 rs2899470 the TT genotype aggravated the condition of endometriosis (OR=2.27, 95%CI 1.05-4.90). However, GSTM1, GSTT1 and GSTP1 rs1695 polymorphisms did not affect the pathogenesis of endometriosis.
Conclusion: Our results suggested that CYP19A1 rs2899470 polymorphism is associated with the risk of endometriosis and the risk of disease.

Entities:  

Keywords:  CYP19A1; Endometriosis; GSTM1; GSTP1; GSTT1

Mesh:

Substances:

Year:  2019        PMID: 30786349     DOI: 10.3760/cma.j.issn.0376-2491.2019.07.008

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Association between single nucleotide polymorphism of the CYP19A1 and ESR2 genes and endometriosis.

Authors:  Beata Smolarz; Hanna Romanowicz
Journal:  Arch Gynecol Obstet       Date:  2021-04-07       Impact factor: 2.344

Review 2.  The Genetic Background of Endometriosis: Can ESR2 and CYP19A1 Genes Be a Potential Risk Factor for Its Development?

Authors:  Beata Smolarz; Krzysztof Szyłło; Hanna Romanowicz
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.